Skip to main content
. 2000 Mar;7(2):279–287. doi: 10.1128/cdli.7.2.279-287.2000

FIG. 5.

FIG. 5

IFN-γ responses of PBMC from an HIV-1-infected, HLA A∗02 B∗27 subject (N4; CD4+ T cell count, 828 cells/mm3; HIV-1 RNA load, not available; not receiving antiretroviral therapy) and an HIV-1-negative, healthy HLA A∗02 subject (7791) to various concentrations of viral peptides representing predetermined CD8+ CTL epitopes. HTLV-1, human T-cell leukemia virus type 1.